correlated with downregulation of B-cell lym-
phoma-2 and upregulation of microRNA-- Oncol Lett 11:817–822
- Esber N, Le Billan F, Resche-Rigon M et al
(2015) Ulipristal acetate inhibits progester-
one receptor isoform A-mediated human
breast cancer proliferation and BCl2-L1
expression. PLoS One 10:e0140795 - Yin P, Lin Z, Cheng Y-H et al (2007) Proges-
terone receptor regulates Bcl-2 gene expres-
sion through direct binding to its promoter
region in uterine leiomyoma cells. J Clin
Endocrinol Metab 92:4459–4466 - Horvath CM (2000) STAT proteins and tran-
scriptional responses to extracellular signals.
Trends Biochem Sci 25:496–502 - Abell K, Watson CJ (2005) The Jak/Stat
pathway: a novel way to regulate PI3K activ-
ity. Cell Cycle (Georgetown, TX) 4:897–900 - Ho HH, Ivashkiv LB (2006) Role of STAT3
in type I interferon responses: negative
regulation of stat1-dependent inflammatory
gene activation. J Biol Chem
281:14111–14118- Jochum W, Passegue E, Wagner EF (2001)
AP-1 in mouse development and tumorigen-
esis. Oncogene 20:2401–2412 - Karin M, Liu Z, Zandi E (1997) AP-1 func-
tion and regulation. Curr Opin Cell Biol
9:240–246 - Tu WH, Thomas TZ, Masumori N et al
(2003) The loss of TGF-βsignaling promotes
prostate cancer metastasis. Neoplasia
(New York, NY) 5:267–277 - Thomsen MK, Bakiri L, Hasenfuss SC et al
(2015) Loss of JUNB/AP-1 promotes inva-
sive prostate cancer. Cell Death Differ
22:574–582 - Birner P, Egger G, Merkel O et al (2015)
JunB and PTEN in prostate cancer: “loss is
nothing else than change”. Cell Death Differ
(4):22, 522–523
276 Faiz M. Khan et al.